ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
What's New in Active Surveillance for Prostate Cancer
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 266527" data-attributes="member: 13851"><p>[MEDIA=youtube]nb-PFvn9rzA[/MEDIA]</p><p>[ATTACH=full]37870[/ATTACH]</p><p></p><p><em><strong>In this video, Dr. Aday discusses the latest advancements in active surveillance for prostate cancer. He explains the history of prostate cancer diagnosis and the limitations of the PSA test. He outlines the criteria for eligibility for active surveillance and the protocol for monitoring patients. Dr. Aday also introduces the concept of focal therapy as a potential treatment option for some patients. He emphasizes the importance of regular follow-ups and discusses the future of prostate cancer treatment.</strong></em></p><p></p><p></p><p><strong>Summary:</strong></p><p></p><ul> <li data-xf-list-type="ul"><em><em>Dr. Aday is a physician at Sloan Kettering and an active surveillance specialist.</em></em></li> <li data-xf-list-type="ul"><em><em>The PSA test was introduced in the 1980s and led to an increase in prostate cancer diagnoses.</em></em></li> <li data-xf-list-type="ul"><em><em>PSA levels alone do not determine the need for immediate treatment.</em></em></li> <li data-xf-list-type="ul"><em><em>Active surveillance involves regular monitoring to detect changes in Gleason grade and other markers.</em></em></li> <li data-xf-list-type="ul"><em><em>MRI has revolutionized the detection and monitoring of prostate cancer.</em></em></li> <li data-xf-list-type="ul"><em><em>Active surveillance is a safe and effective option for low-risk patients.</em></em></li> <li data-xf-list-type="ul"><em><em>Focal therapy is a potential treatment option that targets specific areas of cancer within the prostate.</em></em></li> <li data-xf-list-type="ul"><em><em>Personalized treatment decisions are made based on the patient’s age, comorbidities, and preferences.</em></em></li> <li data-xf-list-type="ul"><em><em>Treatment options include surgery (prostatectomy) and radiation therapy (photon or proton).</em></em></li> <li data-xf-list-type="ul"><em><em>Advances in technology and research continue to improve prostate cancer treatment.</em></em></li> </ul><p></p><p></p><p><strong>Key Takeaways:</strong></p><p></p><ul> <li data-xf-list-type="ul"><em><em>Dr. Aday is an active surveillance specialist at Sloan Kettering. </em></em></li> <li data-xf-list-type="ul"><em><em>The PSA test led to an increase in prostate cancer diagnoses. </em></em></li> <li data-xf-list-type="ul"><em><em>Active surveillance involves monitoring Gleason grade and other markers. </em></em></li> <li data-xf-list-type="ul"><em><em>MRI has revolutionized the detection and monitoring of prostate cancer. </em></em></li> <li data-xf-list-type="ul"><em><em>Active surveillance is a safe option for low-risk patients. </em></em></li> <li data-xf-list-type="ul"><em><em>Focal therapy targets specific areas of cancer within the prostate. </em></em></li> <li data-xf-list-type="ul"><em><em>Treatment decisions are personalized based on age, comorbidities, and preferences. </em></em></li> <li data-xf-list-type="ul"><em><em>Treatment options include surgery (prostatectomy) and radiation therapy (photon or proton). </em></em></li> <li data-xf-list-type="ul"><em><em>Advances in technology and research continue to improve prostate cancer treatment. </em></em></li> <li data-xf-list-type="ul"><em><em>Regular follow-ups are crucial for active surveillance and treatment monitoring. </em></em></li> </ul></blockquote><p></p>
[QUOTE="madman, post: 266527, member: 13851"] [MEDIA=youtube]nb-PFvn9rzA[/MEDIA] [ATTACH type="full" alt="Screenshot (29400).png"]37870[/ATTACH] [I][B]In this video, Dr. Aday discusses the latest advancements in active surveillance for prostate cancer. He explains the history of prostate cancer diagnosis and the limitations of the PSA test. He outlines the criteria for eligibility for active surveillance and the protocol for monitoring patients. Dr. Aday also introduces the concept of focal therapy as a potential treatment option for some patients. He emphasizes the importance of regular follow-ups and discusses the future of prostate cancer treatment.[/B][/I] [B]Summary:[/B] [LIST] [*][I][I]Dr. Aday is a physician at Sloan Kettering and an active surveillance specialist.[/I][/I] [*][I][I]The PSA test was introduced in the 1980s and led to an increase in prostate cancer diagnoses.[/I][/I] [*][I][I]PSA levels alone do not determine the need for immediate treatment.[/I][/I] [*][I][I]Active surveillance involves regular monitoring to detect changes in Gleason grade and other markers.[/I][/I] [*][I][I]MRI has revolutionized the detection and monitoring of prostate cancer.[/I][/I] [*][I][I]Active surveillance is a safe and effective option for low-risk patients.[/I][/I] [*][I][I]Focal therapy is a potential treatment option that targets specific areas of cancer within the prostate.[/I][/I] [*][I][I]Personalized treatment decisions are made based on the patient’s age, comorbidities, and preferences.[/I][/I] [*][I][I]Treatment options include surgery (prostatectomy) and radiation therapy (photon or proton).[/I][/I] [*][I][I]Advances in technology and research continue to improve prostate cancer treatment.[/I][/I] [/LIST] [B]Key Takeaways:[/B] [LIST] [*][I][I]Dr. Aday is an active surveillance specialist at Sloan Kettering. [/I][/I] [*][I][I]The PSA test led to an increase in prostate cancer diagnoses. [/I][/I] [*][I][I]Active surveillance involves monitoring Gleason grade and other markers. [/I][/I] [*][I][I]MRI has revolutionized the detection and monitoring of prostate cancer. [/I][/I] [*][I][I]Active surveillance is a safe option for low-risk patients. [/I][/I] [*][I][I]Focal therapy targets specific areas of cancer within the prostate. [/I][/I] [*][I][I]Treatment decisions are personalized based on age, comorbidities, and preferences. [/I][/I] [*][I][I]Treatment options include surgery (prostatectomy) and radiation therapy (photon or proton). [/I][/I] [*][I][I]Advances in technology and research continue to improve prostate cancer treatment. [/I][/I] [*][I][I]Regular follow-ups are crucial for active surveillance and treatment monitoring. [/I][/I] [/LIST] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
X (Twitter)
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
What's New in Active Surveillance for Prostate Cancer
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top